---
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/291314552.md"
description: "HeartBeam shares are trading higher after the company announced completion of patient enrollment in its ALIGN-ACS pilot study evaluating the HeartBeam System for heart attack detection."
datetime: "2026-06-30T15:31:11.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/291314552.md)
  - [en](https://longbridge.com/en/news/291314552.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/291314552.md)
---

# 

HeartBeam shares are trading higher after the company announced completion of patient enrollment in its ALIGN-ACS pilot study evaluating the HeartBeam System for heart attack detection.

### Related Stocks

- [BEAT.US](https://longbridge.com/en/quote/BEAT.US.md)
- [BEATW.US](https://longbridge.com/en/quote/BEATW.US.md)

## Related News & Research

- [HeartBeam completes enrollment in ALIGN-ACS pilot study for heart attack detection ahead of schedule](https://longbridge.com/en/news/291270595.md)
- [HeartBeam shifts strategy to license 3D ECG platform to partners to drive global adoption](https://longbridge.com/en/news/290733885.md)
- [Amgen says EU CHMP backs broader Repatha use to cut first heart attack, stroke risk](https://longbridge.com/en/news/294212406.md)
- [Pfizer and Eisai Commence Co-promotion of "NURTEC(R)" for the Acute Treatment and Prophylaxis (Preventive Treatment) of Migraine](https://longbridge.com/en/news/293964978.md)
- [NeuroPace's Panel Track Supplement Not Approvable in Current Form, FDA Says](https://longbridge.com/en/news/294121514.md)